The company's high P/E ratio amid shrinking medium-term earn...

Moomoo AI Feb 4, 2024 08:39

The company's high P/E ratio amid shrinking medium-term earnings is worrisome. The market's expected 42% growth next year highlights the company's recent earnings decline. The share price may drop further if business prospects don't significantly improve.

Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHSE:605199) Shares May Have Slumped 25% But Getting In Cheap Is Still Unlikely

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

4409 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

4952

Followers

Following

11K

Visitors